Reactor Issue Could Halt Imaging Tests

The isotope used in radiopharmaceuticals for the majority of nuclear medicine imaging studies could be in short supply until January, following production issues at a Canadian reactor, Reuters reports. Atomic Energy of Canada Ltd. said delays in work on its National Research Universal reactor mean it won't be back up to full capacity until mid-January. Isotopes from that reactor are used by MDS Inc.